Michelle A Ozbun

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Top Venues

Antimicrobial agents and chemotherapy

bioRxiv : the preprint server for biology

Baylor College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Baylor College of Medicine Aug 01 1988 - Jun 01 1994

United States

PHD :: Molecular Virology

Colorado State University Aug 01 1985 - Dec 15 1987

United States

BSC :: Microbiology

Publications

Adrian J Luna, Jesse M Young, Rosa T Sterk, Virginie Bondu, Fred A Schultz, Donna F Kusewitt, Huining Kang, Michelle A Ozbun
Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression. bioRxiv : the preprint server for biology (2023)
Adrian J Luna, Rosa T Sterk, Anastacia M Griego-Fisher, Joon-Yong Chung, Kiersten L Berggren, Virginie Bondu, Pamela Barraza-Flores, Andrew T Cowan, Gregory N Gan, Emrullah Yilmaz, Hanbyoul Cho, Jae-Hoon Kim, Stephen M Hewitt, Julie E Bauman, Michelle A Ozbun
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors. PLoS pathogens 17 (1) (2021)
Jesse M Young, Amira Zine El Abidine, Ricardo A Gómez-Martinez, Virginie Bondu, Rosa T Sterk, Zurab Surviladze, Michelle A Ozbun
Protamine Sulfate Is a Potent Inhibitor of Human Papillomavirus InfectionIn Vitro and In Vivo. Antimicrobial agents and chemotherapy (2021)
Kiersten L Berggren, Sebastian Restrepo Cruz, Michael D Hixon, Andrew T Cowan, Stephen B Keysar, Stephanie Craig, Jacqueline James, Marc Barry, Michelle A Ozbun, Antonio Jimeno, Dennis J McCance, Ellen J Beswick, Gregory N Gan
MAPKAPK2 (MK2) inhibition mediates radiation-induced inflammatory cytokine production and tumor growth in head and neck squamous cell carcinoma. Oncogene 38 (48) (2019)